Finepoint Capital LP Iovance Biotherapeutics, Inc. Transaction History

Finepoint Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$5.62 - $10.0 $227,351 - $404,540	-40,454 Reduced 2.55%	1,545,589 $9.88 Million
Q3 2022 Nov 10, 2022	BUY	$9.53 - $13.11 $5.96 Million - $8.2 Million	625,843 Added 65.18%	1,586,043 $15.2 Million
Q2 2022 Aug 12, 2022	BUY	$6.38 - $18.33 $6.13 Million - $17.6 Million	960,200 New	960,200 $10.6 Million

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.48B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Finepoint Capital LP, based on Form 13F filings with the SEC.

Stay updated on Finepoint Capital LP with notifications on news.